Venture Capital

Young plants in morning light.

Osler has a leading venture capital team dedicated to helping investors and emerging and growth stage companies recognize, develop and realize venture capital opportunities. Our team advises both investors and Canadian companies in the information technology, life sciences, biotechnology, CleanTech and alternative energy sectors accessing private capital, on the unique issues involved in venture capital deals. As an active part of Canada’s burgeoning venture capital ecosystem, we have worked on more than 547 VC deals over the past three years, representing more than $6.57 billion of investment in Canadian private companies.

Our venture capital team comprises passionate and experienced individuals who take a holistic view of the strategic priorities of our emerging companies and venture fund clients in order to build and execute on financing strategies that are consistent with these priorities. In addition to traditional venture capital and angel financings, we have worked on numerous SR&ED-based financings and collaborative research arrangements that access alternative funding sources in addition to venture capital.

Venture capital deal flow

Osler has acted on some of the most prominent venture capital financings in Canadian history, including

2022 Venture Capital Deal Activity

Cross-border expertise

In addition to working with Canadian funds and emerging companies, we advise many U.S. funds on their Canadian investments and in other matters related to their Canadian portfolio companies. Combining our Canadian and U.S. business law services gives us the know-how and experience to support our clients in cross-border matters and provide them with a significant “one-stop” advantage, eliminating the need to retain both Canadian and U.S. counsel.

U.S. and other foreign investors take equity positions in Canadian companies in ways that satisfy their tax objectives and that also preserve relevant tax attributes of the Canadian business. To accommodate these often complex tax issues, our venture capital team collaborates with lawyers in our Tax Group to make sure all tax considerations of a transaction are taken into account. Osler has pioneered some of Canada’s most innovative structures to accommodate the unique regulatory and tax constraints that affect cross-border investments. As a result, lawyers in our tax practice regularly collaborate with our venture capital team.

Exit transactions

Whether as counsel to a Canadian business or to the investors in Canadian companies, we have played a significant role in many notable M&A transactions involving venture-backed Canadian companies. As the leading M&A law firm in Canada, investors and emerging companies rely on our expertise in structuring and negotiating M&A transactions with strategic and financial buyers and on our ability to manage these transactions in a time- and cost-efficient way.

In addition to M&A transactions, we advise Canadian and U.S. private equity funds as well as emerging companies on other forms of exit transactions such as secondary share sales and capital market transactions.

M&A deal flow

Osler has acted on some of the many notable M&A transactions throughout the years, including

Fund formation

Our venture capital team has worked closely with the managers of leading Canadian-focused funds on their fund formation activities. Our immersion in the venture capital and entrepreneurship ecosystem, combined with our involvement in a significant portion of VC financings in Canada, means that we are always on top of market practice, including issues such as fund structure, manager compensation, governance arrangements for the management/GP entity and the amount and structuring of carried interests.

We understand the key issues and considerations that clients need to address and have solved these issues for a number of fund managers.

Some of the current and most often debated issues affecting fund formation today are as follows:

  • General Partner compensation – Many funds are considering a structure involving a General Partner priority distribution instead of only a management fee. We understand the important tax considerations at play.
  • Co-investment rights – General Partners are seeking more flexibility with respect to the structuring of co-investments. This requires careful balancing with conflict of interest considerations.
  • Successor fund issues – General Partners are paying more attention to the parameters governing successor fund raising from the outset.
  • Management fee offset relief – General Partners are exploring alternatives to the traditional 100% offset mechanism for portfolio company fees.

Fund formation

Emerging companies

In addition to our work with established high growth companies, we work closely with emerging companies from incubation throughout their growth cycle to provide practical and cost-effective advice on all aspects of their development and issues that they may face, including corporate and tax structure, financings, IP, employment matters, commercial matters and the preparation for and execution of IPO and M&A transactions.


Ed Vandenberg

Partner, Emerging and High Growth Companies


Chad Bayne

Partner, Emerging and High Growth Companies


Shahir Guindi, Ad. E.

Former National Co-Chair, Partner, Corporate


André Perey

Partner, Emerging and High Growth Companies


Mark Longo

Partner, Emerging and High Growth Companies


Justin D. Young

Partner, Emerging and High Growth Companies


David Jamieson

Partner, Emerging and High Growth Companies


  • Promise Robotics

    Promise Robotics in its closing of a $20.8 million Series A financing round

  • Arteria AI

    Arteria AI in its $46 million Series B financing round

  • Ten Key Labs

    Ten Key Labs in its raising of $10.5 million in Seed financing

  • Relocalize

    Relocalize in its raising of $4.78 million in seed funding

  • Erthos

    Erthos in its $6.5 million Series A financing round

  • Simmunome

    Simmunome in its securing $2 million of pre-seed funding

  • Ontopical

    Ontopical in its raising of $3.3 million in a seed extension financing round

  • FlipGive

    FlipGive in its $5 million Series B financing round

  • Passage

    Passage in its $40 million Seed financing round

  • Ideogram

    Ideogram in its launching of their platform with $22.3 million of seed funding

  • Voiceflow Inc.

    Voiceflow Inc. in its raising of US$15 million

  • Innerspace

    Innerspace in its $10 million Series A financing round

  • Solink

    Solink in its raising of US$60 million in a Series C funding round

  • Vital Biosciences

    Vital Biosciences in its raising of around US$18 million in a Series A financing round

  • Metafold

    Metafold in its of US$1.78 million in Seed financing

  • Shakudo

    Shakudo in its US$7.2 million Series A financing round

  • Hearst Ventures

    Hearst Ventures in connection with Optable’s $20 million Series A financing round

  • Finni Health

    Finni Health in its raising of $3.2 million of seed funding

  • Cohere

    Cohere in its announcement of raising of US$270 million in a Series C financing round

  • BenchSci

    BenchSci in its $95 million Series D Financing round

  • Moxxie Ventures and iNovia Capital

    Moxxie Ventures and iNovia Capital in connection with Spellbook’s US$10.9 million Series A financing round

  • Deep Sky

    Deep Sky in its securing of $10 million of funding

  • VitaminLab

    VitaminLab in its Series A investment round led by Nimbus Synergies and DSM Venturing


    ODAIA in its raising of $34 million Series B financing

  • in its raising of US$85 million Series C financing

  • Find More

Refinitiv: #1 Canadian law firm in the Global Venture Capital League Tables